Reviews in DepthThe role of brachytherapy and Cutting BalloonTM angioplasty in the current treatment of stent restenosisBonan, RaoulAuthor Information Institut de Cardiologie de Montréal, Quebec, Canada Potential conflict of interest: R Bonan is the Medical Director of Novoste Corporation, the company which manufactures the brachytherapy device discussed in this article. Correspondence and requests for reprints to: Raoul Bonan, MD, Institut de Cardiologie de Montréal, 5000 Belanger Street, Montreal, Quebec, H1 T 1C8, Canada Tel: +1 514 376 3330 ext. 3481; fax: +1 514 593 2524; e-mail: email@example.com Coronary Artery Disease: September 2004 - Volume 15 - Issue 6 - p 319-325 Buy Abstract The Gamma I, START and INHIBIT trials conclusively demonstrate the feasibility, safety and efficacy of intracoronary radiation as the treatment of choice for stent restenosis. Further reports confirm this finding and extend the indications. Vascular brachytherapy should be made available for all patients with diffuse stent restenosis. Specific devices such as cutting balloons may improve the procedure but does not seem to have an impact alone on the evolution. © 2004 Lippincott Williams & Wilkins, Inc.